Venturi Wealth Management, LLC Bei Gene, Ltd. Transaction History

Venturi Wealth Management, LLC

$1.77 Billion
Q3 2024

A detailed history of Venturi Wealth Management, LLC transactions in Bei Gene, Ltd. stock. As of the latest transaction made, Venturi Wealth Management, LLC holds 1,600 shares of BGNE stock, worth $349,920. This represents 0.02% of its overall portfolio holdings.

Number of Shares

1,600

Previous 2,824 43.34%

Holding current value

$349,920

Previous $402,000 10.7%

% of portfolio

0.02%

Previous 0.03%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 04, 2024	SELL	$143.93 - $224.51 $176,170 - $274,800	-1,224 Reduced 43.34%	1,600 $359,000
Q2 2024 Jul 19, 2024	SELL	$129.52 - $174.32 $2,719 - $3,660	-21 Reduced 0.74%	2,824 $402,000
Q1 2024 Apr 23, 2024	BUY	$141.8 - $181.47 $187,743 - $240,266	1,324 Added 87.05%	2,845 $444,000
Q4 2023 Jan 23, 2024	SELL	$158.67 - $201.58 $6,664 - $8,466	-42 Reduced 2.69%	1,521 $274,000
Q3 2023 Nov 02, 2023	SELL	$179.87 - $225.13 $84,538 - $105,811	-470 Reduced 23.12%	1,563 $281,000
Q1 2023 May 02, 2023	BUY	$215.53 - $274.5 $33,407 - $42,547	155 Added 8.25%	2,033 $438,000
Q4 2022 Jan 31, 2023	SELL	$125.51 - $229.3 $2,635 - $4,815	-21 Reduced 1.11%	1,878 $413,000
Q3 2022 Nov 14, 2022	BUY	$131.8 - $202.24 $250,288 - $384,053	1,899 New	1,899 $256,000
Q2 2022 Aug 12, 2022	SELL	$121.11 - $216.05 $232,288 - $414,383	-1,918 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$146.52 - $269.56 $16,556 - $30,460	113 Added 6.26%	1,918 $362,000
Q4 2021 Feb 08, 2022	BUY	$248.56 - $389.34 $24,856 - $38,934	100 Added 5.87%	1,805 $489,000
Q3 2021 Oct 19, 2021	BUY	$249.6 - $403.14 $18,969 - $30,638	76 Added 4.67%	1,705 $619,000
Q2 2021 Aug 02, 2021	BUY	$292.75 - $367.01 $26,640 - $33,397	91 Added 5.92%	1,629 $559,000
Q1 2021 Apr 22, 2021	BUY	$260.64 - $382.12 $107,644 - $157,815	413 Added 36.71%	1,538 $535,000
Q4 2020 Jan 28, 2021	BUY	$221.31 - $316.61 $43,819 - $62,688	198 Added 21.36%	1,125 $291,000
Q3 2020 Nov 03, 2020	BUY	$189.18 - $286.44 $168,559 - $255,218	891 Added 2475.0%	927 $266,000
Q3 2019 Oct 29, 2019	BUY	$120.61 - $148.29 $4,341 - $5,338	36 New	36 $4,000

Others Institutions Holding BGNE

# of Institutions

253

Shares Held

45.3M

Call Options Held

292K

Put Options Held

119K

View Full List

About BeiGene, Ltd.

Ticker BGNE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 103,700,000
Market Cap $22.7B
Description
BeiGene, Ltd., a biotechnology company, focuses on discovering, developing, manufacturing, and commercializing various medicines worldwide. Its products include BRUKINSA to treat relapsed/refractory (R/R) mantle cell lymphoma; Tislelizumab to treat R/R classical Hodgkin's lymphoma; REVLIMID to treat multiple myeloma; VIDAZA to treat myelodysplas...

More about BGNE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Venturi Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Venturi Wealth Management, LLC with notifications on news.

Account

Venturi Wealth Management, LLC Bei Gene, Ltd. Transaction History